Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-10-22

Clinical Trial Update: Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems [Phase 2]

View source ↗

Summary

Phase 2 trial update describing the safety and effectiveness of tadalafil for benign prostatic hyperplasia. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Prostatic Hyperplasia, Prostate | Phase 2 | Status: COMPLETED